Executive Summary: The global herpes zoster drug market was valued at USD 1.23 billion in 2024 and is expected to reach USD 3.31 billion by 2032 at the CAGR of 13.20% during the forecast period  The global Herpes Zoster Drug Market is witnessing dynamic growth as industries adapt to changing consumer behaviors, technological advancements, and...